|Articles|February 11, 2009
Lucentis vs PDT: which is more cost-effective?
Cost-effectiveness of ranibizumab compared with photodynamic treatment of neovascular age-related macular degeneration
Advertisement
Please click
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Q&A: What the FDA’s class-wide NAION warning on GLP-1s means for eye care
2
Dazodalibep data put Sjögren screening in focus for ophthalmologists
3
How Lambert-Eaton myasthenic syndrome presents around the eyes
4
The interplay between cardiac disease and the eye
5













